The EIF5A2 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of mouse embryonic stem cells harboring targeted disruption of the Eif5a2 gene. This polyclonal model provides a heterogeneous loss-of-function system suitable for studying the hypusine-containing translation elongation factor EIF5A2 in a pluripotent stem cell background. The gene disruption eliminates functional EIF5A2 protein expression, enabling investigation of its roles in translational control, cell proliferation, and apoptosis without introducing a defined clonal editing pattern.
The MES-OV host cell line is an embryonic stem cell line derived from the inner cell mass of a 129/Sv mouse blastocyst. These cells exhibit hallmark pluripotency, retaining the capacity for indefinite self-renewal in culture while maintaining the potential to differentiate into derivatives of all three germ layers. As a well-characterized pluripotent model, MES-OV cells are widely employed in developmental biology and stem cell research, providing a relevant cellular context for dissecting molecular mechanisms that govern early mammalian development, lineage commitment, and maintenance of the undifferentiated state.
EIF5A2 functions as a specialized translation elongation factor that alleviates ribosome pausing at polyproline motifs, thereby facilitating synthesis of proteins containing such stretches, including the tumor suppressor p53 and various cyclins. Its activity is contingent upon post-translational hypusination, a unique modification catalyzed sequentially by deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH). Hypusinated EIF5A2 associates with the 60S ribosomal subunit to promote efficient peptide bond formation. Upstream, EIF5A2 expression is transcriptionally activated by MYC and its translation is stimulated through mTOR/S6K1 signaling in response to growth factors such as EGF and insulin, linking nutrient and mitogenic signals to selective mRNA translation. Consequently, EIF5A2 integrates mTOR and MYC pathways to drive cell cycle progression and suppress apoptosis, and its dysregulation is implicated in hepatocellular carcinoma, ovarian cancer, and colorectal cancer.
In MES-OV embryonic stem cells, knockout of EIF5A2 is predicted to impair translation of polyproline-rich proteins essential for self-renewal and differentiation. Attenuated synthesis of p53 and cyclins may disrupt normal cell cycle checkpoints and apoptotic thresholds, potentially altering the balance between pluripotency and lineage commitment. This polyclonal knockout model therefore offers a powerful tool to mechanistically interrogate how translational elongation control influences stem cell fate decisions, epigenetic remodeling, and the transition from pluripotency to differentiation. It also provides a platform for exploring whether hypusination-dependent translation represents a vulnerability in EIF5A2-driven cancers.
Applications include examining translational regulation of pluripotency factors during stem cell differentiation, assessing oncogenic functions via rescue experiments, and screening small-molecule inhibitors of the hypusination pathway. Representative assays comprise western blotting for total and hypusinated EIF5A2, RT?qPCR for Eif5a2 mRNA, polysome and ribosome profiling to monitor translation elongation dynamics, MTT?based proliferation assays, Annexin V apoptosis detection by flow cytometry, and immunofluorescence staining of pluripotency markers Oct4 and Nanog. These workflows facilitate comprehensive phenotypic and mechanistic analyses. For further technical specifications or ordering inquiries, please contact Ascent Research.
